An important therapy for #COVID19 appears quite promising. A human monoclonal antibody blocking SARS-CoV-2 infection | Nature Communications https://t.co/iKGhOKcPxN
RT @datagramtwo: @GreatGameIndia @WHO #EFFITYLER #TYLER #NOCONSENT MORE BIOWEAPON CONFESSIONS.... https://t.co/07jmHCmJK3 Production of h…
RT @YAYshamsaldeen: دراسة مخبرية من جامعة أوتريخت🇳🇱، اجريت على خلايا كلى قرد🐒VeroE6 الدراسة أنتجت أجسام مضادة (47D11H2L2) في🐁تجارب ثم تحو…
Wang, C., Li, W., Drabek, D. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11, 2251 (2020). https://t.co/GQq4jXyMuJ
@influenzer3 短期的なIgG群の減少だけでなく 抗体そのもののこのウイルスに対する働きの 特異性につながるかもしれないと感じました 既に既読かもしれませんがよろしければ (私の場合はこれとつながりぼんやりとした仮説というか 妄想wが) https://t.co/zioa1NdTxu
RT @djdegaf: the first: doing science to find a cure for covid. the second: migrated to the west to feel the rainbow. read her research wi…
RT @djdegaf: the first: doing science to find a cure for covid. the second: migrated to the west to feel the rainbow. read her research wi…
RT @djdegaf: the first: doing science to find a cure for covid. the second: migrated to the west to feel the rainbow. read her research wi…
RT @djdegaf: the first: doing science to find a cure for covid. the second: migrated to the west to feel the rainbow. read her research wi…
RT @djdegaf: the first: doing science to find a cure for covid. the second: migrated to the west to feel the rainbow. read her research wi…
the first: doing science to find a cure for covid. the second: migrated to the west to feel the rainbow. read her research with other scientists: https://t.co/8zMoapwrzn #ExMuslim https://t.co/Lw32APplCJ
@pcr_wada_com ② https://t.co/E5X4mU5gxZ https://t.co/zioa1NdTxu https://t.co/CEsPAsaLCE 読みかけが、あと3本ほどあるのですが、未精読の為送らずに置きます
https://t.co/zioa1NdTxu この論文で単体抗体が初めて特定 最近2つ論文出てるけど、精読中とブックマークあちこちで取り敢えず 抗体検査は調査用としては有用と思います ただ東京1900人はまだまだ少ない(東京人口1400万人)、目安になるが… 今後もっとやってくれないとこちらも正確な統計不能かと…
免疫学:SARS-CoV-2に対する中和抗体の特定 | Nature Communications | Nature Research: https://t.co/67bhH90xcT
Invitrogen Alexa Fluor 594 goat anti-human IgG Ab assisted in this SARS-CoV-2 study. #thermofisheremp https://t.co/u8k30TjDm8
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
A human monoclonal antibody blocking SARS-CoV-2 infection | Nature Communications https://t.co/MKVcoAf67N
RT @joseukscience: El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso…
El primer anticuerpo neutralizante (es decir que neutraliza el virus SARS-COV-2) podrá estar listo en 6 meses , incluso antes que la vacuna. @microBIOblog @gorka_orive https://t.co/54eOrGrWgB
RT @DavidEarlie2: A human monoclonal antibody blocking SARS-CoV-2 infection | Nature Communications https://t.co/QHqNZCvrQg
A human monoclonal antibody blocking SARS-CoV-2 infection https://t.co/RxwENqaLuw
A human monoclonal antibody blocking SARS-CoV-2 infection https://t.co/6IcFQ63HK1
Sars 2 Human Rights https://t.co/xdgCsSx35j
Slam FM https://t.co/xdgCsSx35j
RT @BioTodaySuppl: AbbVie will receive an option to exclusively license ユトレヒト大学等が見つけて先月Nature姉妹誌に報告された新型コロナウイルス中和抗体をAbbVieが予約。前臨床開発を支援し、臨床開…
AbbVie will receive an option to exclusively license ユトレヒト大学等が見つけて先月Nature姉妹誌に報告された新型コロナウイルス中和抗体をAbbVieが予約。前臨床開発を支援し、臨床開発と販売を一手に引き受ける権利を頃合いを見て選択可能。 https://t.co/voCEunrqVI https://t.co/DNeQ5xbp7C
Apparently $ABBV was intriged, and got an exclusive option to license the project. https://t.co/C2tQ6Qvlu6
#COVID19 $ABBV AbbVie, Harbour BioMed, @UtrechtUni & @ErasmusMC announced a collaboration to develop a monoclonal antibody therapy (named 47D11) against SARS-CoV-2. Discovery of the antibody was published in @NatureComms: https://t.co/flgBDqvwQy http
.@abbvie to support work on #COVID19 neutralizing #antibody #47D11 @Harbour_Biomed, @UtrechtUni & @ErasmusMC Receives option to license anti-spike #immunotherapy for clinical dev’t https://t.co/JVspepQgJc #infectiousdiseases @NatureComms https://t.co
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
RT @DrBioblogo: Identifican en una colección de anticuerpos de SARS-CoV un anticuerpo humano capaz de bloquear la infección por #SARSCoV2 e…
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
RT @CaKizil: Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde…
Birçok çalışmada antikor tipleri incelendiğinde virüsü nötralize edebildiği, yani ona sıkıca bağlanıp işlevini etkili şekilde azalttığı, gösterilen antikorlar gösterildi. https://t.co/4zrF2l3s7o https://t.co/Tw5N3EEsIa
A human monoclonal antibody blocking SARS-CoV-2 infection #koronafi https://t.co/Bw8CH0KOSY
$ATNM AWE Antibodies are the next generation therapeutics of monoclonal antibody therap which are linked to be used for #COVID19 patients.@ActiniumPharma
@sfsutcliffe @TeunkeA @equibotanica @Boyanbc Probably related this study (haven't read it yet): https://t.co/QVJgFRvpEg
$ATNM Covid 19 https://t.co/xgkoszl25x $bmy $mrk $nvs $pfe $abbv $NVAX $MRNA @JNJCares @bmsnews @Merck #pennystocks #covid19 $ibio
$ATNM AWE Technology could potentially be used for #Covid A human monoclonal antibody blocking SARS-CoV-2 infection | Nature Communications. @ActiniumPharma $bmy $mrk $nvs $pfe $abbv $NVAX $MRNA @JNJCares @bmsnews @Merck https://t.co/aPO4UySf9x
Monoclonal Antibody (Passive Immunotherapy) is a boon to fight against COVID-19 Infection https://t.co/c8X5uxoXvN https://t.co/R3f0krnMZt
RT @DrBioblogo: Identifican en una colección de anticuerpos de SARS-CoV un anticuerpo humano capaz de bloquear la infección por #SARSCoV2 e…
RT @lafdez_synbio: Another example of a human mAb neutralizing SARS-CoV2, again from SARS 2003 patients and not inhibiting binding of RBD t…
RT @lafdez_synbio: Another example of a human mAb neutralizing SARS-CoV2, again from SARS 2003 patients and not inhibiting binding of RBD t…
RT @lafdez_synbio: Another example of a human mAb neutralizing SARS-CoV2, again from SARS 2003 patients and not inhibiting binding of RBD t…
RT @alfonslopeztena: Report on a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This coronavirus cro…
Another example of a human mAb neutralizing SARS-CoV2, again from SARS 2003 patients and not inhibiting binding of RBD to ACE2 https://t.co/F5c7tGnFAP
Monoclonal Antibody behaves as an antiviral agent against coronavirus https://t.co/rd0yv25j3k https://t.co/opMPV4msOj
@nicomerchante @florian_krammer Esencial para no improvisar. Y también planificar grupos que se podrían beneficiar de una inmunizaon pasiva con anticuerpos monoclonales https://t.co/b4eAdldwiv
RT @csentropy: "A human monoclonal antibody blocking SARS-CoV-2 infection" An interesting fact is it works different from receptor-binding…
"A human monoclonal antibody blocking SARS-CoV-2 infection" An interesting fact is it works different from receptor-binding interference https://t.co/MaLqmjyYF8
紹介した論文 免染結果はここから拝借しました https://t.co/sXvrd9TVdE
Agent that “Neutralises” Covid-19, so could be used as a treatment for our sickest patients to help them fight the virus. As though they had antibodies already 🙂🌈👏🏼 A human monoclonal antibody blocking SARS-CoV-2 infection | Nature Communications https://
También podría estar sola en el billete sin la compañía de nadie. Por quien fue, bien lo tiene merecido
How did I miss this paper from a few weeks ago? This is the best news I've seen on the immunity front yet. A SARS antibody neutralizes SARS-CoV-2! "A human monoclonal antibody blocking SARS-CoV-2 infection" https://t.co/w9inz5cGYT
RT @RheumNow: Nature communications researchers have identified a (human) monoclonal antibody (47D11) that neutralizes SARS-CoV-2 by bindin…
Nature communications researchers have identified a (human) monoclonal antibody (47D11) that neutralizes SARS-CoV-2 by binding to spike protein in cultured cells. Not yet tried a a therapy in humans. https://t.co/PXfc7NNGb4
Más sobre anticuerpos neutralizantes.
オランダのグループに続いてスイスのグループによるSARS-CoV-2モノクローナル中和抗体の報告。先の報告と同様に交差中和抗体でRBDドメインに結合するが、ACE2受容体への結合と競合しない。 Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody https://t.co/FVgoDVIIQ2
RT @Kannan9900: Some GOOD news on the development of Monoclonal antibody for Covid19. Experimental proof showing this is neutralizing antib…
Anticorpo que VENCE Corona Vírus em laboratório. É a solução? Fonte científica: https://t.co/HZCZg4fINL https://t.co/rkk4fuluP6
In other COVID-19 science news, a recombinant version of a human SARS antibody appears to have anti-viral activity against the coronavirus. This is a long way from the clinic but provides another potential option if vaccines don’t work. https://t.co/S3fsb
A human monoclonal antibody blocking SARS-CoV-2 infection | Nature Communications https://t.co/QHqNZCvrQg
RT @FUTURENEWS2020: While rooting for monoclonal approaches, a Mix of common human IGs(immunoglobulins(is a part of a therapeutic approach…
Importante noticia cientifica: un grupo de investigación en Holanda afirma en Nature Communications, haber desarrollado un anticuerpo monoclonal totalmente humano que evita que el SARS-CoV-2 infecte las células cultivadas. https://t.co/PPOTfTG4Sv
Researchers at Utrecht University, and Harbour BioMed had successfully identified a fully human monoclonal antibody, that has the potential to prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells and can also neutralize the virus. DOI ht
From the freezer, redux: #47D11 antibody neutralises SarsCoV's , not by receptor-binding interference but impairing spike mediated syncytia formation. Ab's to non-overlapping epitopes may act synergistically->lower dosage, mitigate risk of immune escape
@YAYshamsaldeen https://t.co/fqhPwJwFEh سلام عليكم د/يوسف مساء الخير، ما رأيك في البحث العلمي المنشور بخصوص اكتشاف الجسم المضاد لكوفيد١٩. شكراً لسعة صدرك 😊 https://t.co/EDMUGdYcWm
@ChimicoScettico real ?
A human monoclonal antibody blocking SARS-CoV-2 infection https://t.co/ZnS2iHZnIi
RT @milamorcor: Link do artigo publicado dia 4 desde mês pela NATURE sobre anticorpos que neutralizam o vírus IN VITRO. Há outros estudos s…
RT @S_Ordibehesht: @timeshighered @higherbaker @NatureComms 'Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SA…
@timeshighered @higherbaker @NatureComms 'Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This crossneutralizing antibody ... may offer potential for prevention and treatment of #COVID19.'* — C Wang, e
RT @S_Ordibehesht: @timeshighered @higherbaker 'Further work then established that one antibody could actually block Sars-CoV-2 – as well a…
@timeshighered @higherbaker 'Further work then established that one antibody could actually block Sars-CoV-2 – as well as Sars-Cov, the coronavirus that causes Sars − from infecting cells in a lab environment.' — Simon Baker, THE | #COVD19 ___ Publication
RT @NatureComms: Researchers @UniUtrecht identify a human monoclonal antibody blocking SARS-CoV-2 infection in cell culture #COVID19 http…
RT @NatureComms: Researchers @UniUtrecht identify a human monoclonal antibody blocking SARS-CoV-2 infection in cell culture https://t.co/t…
RT @sinwanohate: コロナウイルスが細胞表面受容体ACE2へ結合するのを抑えるヒト由来モノクローナル抗体を作成したという論文2報。ヒト由来なら安全性高いのかな。モノクローナル抗体ならたくさん作れるだろう。細胞への感染抑制なら感染初期だよね。やっぱり検査。 http…
RT @floszcrxl: Dutch researchers: in talks to develop antibody treatment for coronavirus https://t.co/KilKTausEx Online press conference 1…
RT @DeliaCortesGuir: Human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture and may offer potential for preve…
免疫学:SARS-CoV-2に対する中和抗体の特定 | Nature Communications | Nature Research https://t.co/CgOUrz4Jqg
RT @pettet50: Dutch hospital and researchers have come up with this possible solution to getting infected with covid-19. Animal testing are…
RT @Khashab_AA: بحث رائع عن استحداث الأجسام المضادة لمنع تفشي الفيروس عند الاصابه. A human monoclonal antibody blocking SARS-CoV-2 infecti…